t
On 6 October 2021, Empyrean Energy plc received notice for the exercise of warrants over 200,000 Ordinary Shares at 12p each, for which £24,000 was received. The company will issue 200,000 replacement incentive warrants at 12p expiring 22 October 2022 and 200,000 bonus warrants at 18p expiring 22 July 2023. Following expected admission on 12 October 2021, Empyrean's enlarged issued share capital will comprise 573,329,113 ordinary shares.
| Date | 6 Oct 2021 |
| Time | 10:22:21 |
| Category | Capital structure |
| ID | 2123O |
6 October 2021
Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas
Empyrean Energy plc
Exercise of 12p Warrants
Empyrean Energy ("Empyrean" or the "Company"), the oil and gas development company with interests in China, Indonesia and the United States, advises that it has received a notice to exercise warrants (exercise price 12p per Warrant) over a total of 200,000 Ordinary Shares (the "Warrant Shares"), for which funds of £24,000 have been received by the Company.
Application will be made for the admission of the Warrant Shares to trading on AIM ("Admission"). Admission is expected to take place on 12 October 2021. The Warrant Shares will rank pari passu with the existing ordinary shares on issue.
The Company will also issue 200,000 replacement incentive warrants expiring 22 October 2022 with an exercise price of 12p and 200,000 bonus warrants expiring 22 July 2023 with an exercise price of 18p, in accordance with the terms of the warrants being exercised, as detailed in the announcement on 9 July 2021.
Following Admission, the Company's enlarged issued share capital will comprise 573,329,113 ordinary shares of 0.2p each (the "Shares"), each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
-ENDS-
For further information please contact the following:
|
|
||||||||||||||
|
|
|
||||||||||||||
|
|
|
||||||||||||||
|
|
|